Cost effectiveness of the NHS breast screening programme: Life table model

BMJ (Online)

Volumn 346, Issue 7911, 2013, Pages

  Pharoah, Paul D P ^a   Sewell, Bernadette ^b   Fitzsimmons, Deborah ^c   Bennett, Hayley S ^b   Pashayan, Nora ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; MAMMOGRAPHY; MORTALITY; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; UNITED KINGDOM;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COST-BENEFIT ANALYSIS; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; LIFE TABLES; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; RISK; WALES;

EID: 84878833271     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f2618     Document Type: Article

References (15)

1. Forrest APM. Breast cancer screening: report to the health ministers of England, Wales, Scotland, and Northern Ireland by a working group. Department of Health and Social Security, 1987.
2. International Agency for Research on Cancer. Handbook of cancer prevention: breast cancer screening, volume 7. IARC, 2002.
3. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med 2009;151:727-37, W237-42.
4. Woolf SH. The 2009 breast cancer screening recommendations of the US Preventive Services Task Force. JAMA 2010;303:162-3.
5. Tonelli M, Gorber SC, Joffres M, Dickinson J, Singh H, Lewin G, et al. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ 2011;183:1991-2001.
6. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011;1:CD001877.
7. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380:1778-86.
8. Office of National Statistics. Reference table: population estimates for England and Wales, mid-2002 to mid-2010 revised (national). 2012. www.ons.gov.uk/ons/taxonomy/index.html?nscl=Population#tab-data-tables.
9. Puliti D, Miccinesi G, Zappa M, Manneschi G, Crocetti E, Paci E. Balancing harms and benefits of service mammography screening programs: a cohort study. Breast Cancer Res 2012;14:R9.
10. Jorgensen KJ, Gotzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339:b2587.
11. Madan J, Rawdin A, Stevenson M, Tappenden P. A rapid-response economic evaluation of the UK NHS Cancer Reform Strategy breast cancer screening program extension via a plausible bounds approach. Value Health 2010;13:215-21.
12. Boer R, de Koning H, Threlfall A, Warmerdam P, Street A, Friedman E, et al. Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study. BMJ 1998;317:376-9. (Pubitemid 28359308)
13. Bryan S, Brown J, Warren R. Mammography screening: an incremental cost effectiveness analysis of two view versus one view procedures in London. J Epidemiol Community Health 1995;49:70-8.
14. Johnston K, Brown J. Two view mammography at incident screens: cost effectiveness analysis of policy options. BMJ 1999;319:1097-102. (Pubitemid 29494718)
15. Cole JA, Lawinski CP, Clinch PJ, Emerton DP, Mackenzie A. Cost-effectiveness of full field digital mammography and computed radiography versus film/screen imaging for mammography. Centre for Evidence Based Purchasing, 2008.